Loading
LOADING
Curious about interaction or interference when running PT-141 (bremelanotide) alongside metabolic peptide protocols. Melanocortin receptor activity could theoretically affect appetite signaling separately from the GLP-1 path.
Is anyone tracking interactions? Or is everyone treating these as separate protocols?
No comments yet. Start the thread.